Dr. Dimitrios George Tsakos, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 399 South Route 45, Lindenhurst, IL 60046 Phone: 847-356-2066 Fax: 847-356-2194 |
Dr. Dierdre Banina Schneider, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 399 South Route 45, Lindenhurst, IL 60046 Phone: 847-356-2066 |
Tiffani Aytch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 399 S Us Highway 45, Lindenhurst, IL 60046 Phone: 847-356-2066 Fax: 847-356-2194 |
Janet Haro Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2020 E Grand Ave, Lindenhurst, IL 60046 Phone: 847-356-4302 |
Gordana Quiros, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2884 Falling Waters Dr, Lindenhurst, IL 60046 Phone: 847-917-1790 |
Loring Krich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2020 E Grand Ave, Lindenhurst, IL 60046 Phone: 847-356-4302 |
Fida Momani Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2020 E Grand Ave, Lindenhurst, IL 60046 Phone: 847-356-4302 |
Jennifer Nadra Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 399 S Us Highway 45, Lindenhurst, IL 60046 Phone: 847-356-2066 |
Amy Christine Kaylor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 234 Thrush Cir, Lindenhurst, IL 60046 Phone: 847-356-2364 |
Rachael A Deck, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2880 Trail Crest Ln, Lindenhurst, IL 60046 Phone: 630-399-2096 |
Dr. Bradley Dietz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 399 South Route 45, Lindenhurst, IL 60046 Phone: 847-356-2066 Fax: 847-356-2194 |
News Archive
Cancer patients referred to Hôpital Riviera's (Vevey, Switzerland) new radiotherapy clinic will soon benefit from the center's acquisition of Elekta's advanced new linear accelerator, Versa HD.
Dr. Michael Kaplitt, a professor of neurological surgery at Weill Cornell Medicine and a longtime leader in developing cutting-edge surgical therapies for movement disorders, leads a team that has been awarded a three-year, $8.9 million grant from the Aligning Science Across Parkinson's (ASAP) initiative.
Fibrotech, an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis, today announced that its lead anti-fibrotic compound FT011 has successfully completed a Phase Ia trial in healthy volunteers demonstrating safety and tolerability up to doses of 1000mg.
The OPTIMISTIC study, an innovative initiative developed by research-clinicians from Indiana University and the Regenstrief Institute to improve health care, reduce avoidable hospitalizations and increase access to palliative care, is now underway in 19 nursing facilities throughout Central Indiana.
› Verified 3 days ago